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Biofilms associated with human infection have high levels 
of pathogenicity due to their resistance to antibiotics. The 
discovery of an active antibiofilm agent against polymicrobial 
biofilms is a necessary consequence for coping with biofilm-
related infections. Thymol and Eugenol are essential oils that 
have potential as antibacterial and antifungal. This study aimed 
to determine the effectiveness of thymol and eugenol inhibits C. 
albicans, P. Aeruginosa, E. coli S. aureus and polymicrobial 
biofilm. Biofilm formation inhibition assay and biofilm 
degradation assay of thymol and eugenol were determined using 
microtiter broth method.The antibiofilm efficacy of thymol and 
eugenol towards polymicrobial biofilms were analyzed by 
calculating minimum biofilm inhibitor concentration (MBIC50) and 
minimum biofilm eradication concentration (MBEC50) values. The 
data were analyzed using Statistical Package for the Social 
Sciences (SPSS) with 95% confidence level. Thymol and eugenol 
showed inhibitory activity against the formation of mono and 
polymicrobial biofilms of the microbial tested.The result also 
demonstrated an evidence of activity of thymol and eugenol in 
breaking down mono and polymicrobial biofilm. Therefore, 
thymol and eugenol serves as a potential source for new 
antibiofilm drugs towards polymicrobial biofilm. 
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INTRODUCTION  
Biofilm-related infections are an 
increasing health problem worldwide, especially 
patients suffering from immune system 
disorders such as HIV, cancer, organ transplants 
and malnutrition. Biofilm associated with 
human infection may contribute tomicrobial 
resistance towards antibiotic used. It is estimated 
that 65% of all hospital-related infections is 
caused by biofilms which includes its attachment 
on medical devices such as catheters and 
biomaterials (Furukawa et al., 2006). Biofilm in 
nature consists of mixture of various strain and 
even various species of microbes living 
together. The microbial diversity in 
polymicrobial biofilms adds complexity in the 
eradication process (Liu et al., 2000). 
Many recent research on biofilm 
eradication have been done on single species 
microbial biofilms. However, polymicrobial 
biofilms can cause chronic infections while 
synergistic interactions in of the polymicrobials 
affects the physiological function of biofilms by 
resulting increased resistance and virulence 
(Burmølleet al., 2014). The formation of 
biofilms from both bacterial polymicrobials 
(Gram positive and Gram negative) as well as 
fungi especially from the genus C. albicans is 
responsible for the onset of disease in humans. 
Some literature explain that bacteria 
synergistically can form biofilms with other 
bacterial species, and physically and 
physiologically the structure of the biofilm 
becomes thicker and stronger (Anderssonet al., 
2008; Cowan et al., 2003; Leriche et al., 2003). 
 
Thymol and Eugenolare both found in 
plant essential oils. Thymol has a broad 
spectrum antimicrobial activity, and has been 
the subject of several studies in vitro (Dorman 
and Deans, 2000).Thymol and eugenol had 
activity inhibit mono-species biofilm S. aureus 
and E. coli (Nestro et al., 2007; Kim et al., 2016). 
Despite being potential as antibiofilm against 
single species microbes, no reports on their 
effects eugenol against polymicrobial biofilms 
consists of P. aeruginosa, E. coli, S. aureus, C. 
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albicans. Research on such topic is essential to 
evaluate the effectiveness of eugenol and 
thymol, as antibiofilm in polymicrobial cultures. 
 
MATERIALS AND METHODS 
Materials used were thymol (Sigma-
Aldrich, Germany), eugenol (Sigma-Aldrich, 
Germany), crystal violet (Merck, Germany), 
ethyl acetate (Merck, Germany), Brain Heart 
Infusion (Oxoid) (Merck, Germany), ethanol 
95% (Merck, Germany), nystatin (Sigma-




Some equipments used in this research 
were Laminar Air Flow, incubator (IF-2B) 
(Sakura, Japan), micropipette pipetman (Gilson, 
France), multichannel micropipette (Socorex, Swiss), 
microplate flat-bottom polystyrene 96 well (Iwaki, 
Japan), mikrotiter plate reader (Optic  Ivymen 
System 2100-C, Spain), spectrophotometry 
(Genesys 10 UV Scanning, 335903) (Thermo 
Scientific Spectronic, USA),  autoclave  (Sakura, 
Japan), analytical scales (AB204-5, Switzerland). 
 
Bacterial Strains 
A standardstrain of Saureus ATCC 
25923, Ecoli ATCC 25922, Paeruginosa ATCC 
27853, wascultured in tryptic soy broth (TSB) 
medium and incubated at 37ºC for 72h. 
Calbicans ATCC 10231 was cultured in 
Sabouraud Dextrose Broth (SDB) medium and 
incubated at 37ºC withagitation (120rpm) for 
24h. The optical densities (OD600) of microbial 
cultures will be adjusted to 0.1 (equal of the 0.5 
McFarland standard ~1.5x108 CFU/mL), and 
subsequently diluted in fresh medium to 
OD600 0.01 for each microbial species.  
 
Biofilm Formation Inhibition and Biofilm 
Eradication Assay in Vitro 
In order to determine the isolate eugenol 
and thymol activity toward formation and 
degeneration of biofilm, a microtiter plate 
polystyrene flat bottom 96-well was used (Pierce 
et al., 2008). A 100µL of C. albicans suspension 
(107 CFU/mL) was inserted in each well 
microtiter plate, C. albicans were incubated                  
at  37ºC for         90min for biofilm-adhesion  phase. 
 
After the incubation, plates were washed using 
150µL of sterile aquadest for three times in 
order to nullify the non-adhesive cells. A 100µL 
of media contained eugenol and thymol with 
different concentrations (1% v/v, 0.5% v/v, 
0.25% v/v, 0,125% v/v), was added to each 
washed-well. Media with methanol were used as 
diluting controland microbe suspensions were 
used as negative control. As the positive 
control, a microbe suspension with nystatin 1% 
was used, and a media without microbe growth 
was used as media control. The plates were 
incubated in 37°C for 24h to form the mid-
phase biofilm and 48h for maturating phase. 
Plates were washed with distilled water for 
three times. A 125µL solution of crystal violet 
1% was added to each well in order to color the 
formed biofilm. The plates were incubated in a 
room temperature for 15min. After incubation, 
the microplates were washed with running 
water for three times to clean the crytal violet’s 
remains and A 200µL of ethanol 96% was 
added to each well. The Optical Density (OD) 
reading was performed with microplate reader 
on the wavelength of 595nm. The testing was 
performed in three times replication. The 
percentage of inhibition and degeneration for 
every eugenol and thymol concentration was 
counted using the formula below: 
 
Od growth control – Od sample 
x 100 
Od growth control 
 
The amount of sample that could inhibit 
at least 50% of the biofilm formation can be 
considered as minimum biofilm inhibitory 
concentration (MBIC50) and minimum biofilm 
eradication concentration (MBEC50) (Pratiwi et 
al 2015). The testing for polymicrobial biofilm               
C. albicans, E. coli, P. aeruginosa and S. aureus 
was performed under the same methods 
with the monospecies C. albicans. In other 
hand, the biofilm testing towards E. coli, P. 
aeruginosa and S. aureus was similar to the 
monospecies testing without incubation of 
C. albicans at ±37ºC for 90min for adhesion 
phase. A microbial suspension that already 
given an antibiotic namely chloramphenicol 1% 
v/v, was used as control-antibiotic. 
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RESULT AND DISCUSSION 
Crystal violet assay for staining biofilm 
Crystal violet staining is commonly used 
for quantification of biomass biofilm formation 
in various types of microorganisms. Crystal 
violet binds the negative charge on the surface 
of the molecule and polysaccharide to EPS so 
that crystal violet remains attached to the 
biofilm after being washed with distilled water 
(Peeters et al., 2008). Crystal violet was used to 
show the quantity of biofilm mass (Stepanovic 
et al., 2000). Crystal violet is bound to molecular 
surface negative ions and polysaccharides present 
in the extracellular matrix (Li et al., 2003). 
Biofilm formation can be seen in the 
microplate base after administration of crystal 
violet (Figure 1). Figure 1.C shows that the 
intensity of crystal violet staining is very clear, 
this showed that the composition of biofilm 
numbers located in these wells is very thick and 
strong where the biofilm is not well formed. 
Whereas in figure 1.B the intensity of 
crystal violet staining is not as close as in Figure 
1c.This indicates that biofilm formation is not 
completely formed. This inhibiting mechanism 
is caused by thymol compounds that inhibit  
polymicrobial biofim. Therefore, one bacterium 
was unable to form a community with other 
bacteria. 
In figure 1. A, the intensity of staining of 
violet crystals is very low indicating that the 
biofilms formed are less than in figure 8.C and 
8.B. This showed the inhibition of biofilm 
formation because the eugenol compound can 
inhibit the formation of S. aureus, P. aeruginosa,     
E. coli and C. albicans to form complex biofilm 
communities. 
 
Effectof thymol and eugenol against 
mono-speciesmid – phase biofilm (24h) 
In this study we evaluated the 
antibiofilm potencies of thymol and eugenol, 
each against polymicrobial and mono-species 
biofilms. We observed a decline in the rate of 
biofilm formation along with the increased 
concentrations of thymol and eugenol. The 
formation of C. albicans biofilm begins with the 
attachment of cells to host cells which last 
between 0-2h continuing with hyphae formation 
(4-6h). The hyphae yarns form a monolayer            
(6-8h) that will proliferate (8-24h) to then 
maturate (24-48h) (Ramage et al., 2001).  
 
 
Figure 1. Crystal violet assay to see the formation of biofilm, a. Polymicrobial biofilm by 
adminitration of eugenol compounds; b. Polymicrobial biofilm by adminitration of thymol 
compounds; c. Polymicrobial biofilm without adminitration of test compound 
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The results of this study showed that the 
formation of mid-phase biofilms of P. aeruginosa, 
E. coli, C. albicans and S. aureus decreased with 
increasing concentrations of thymol 
compounds (Table I and Figure 2). Eugenol 
showed inhibitory activity against mid-phase 
mono-species and polymicrobials biofilm. The 
formation of mid-phase biofilms of P. 
aeruginosa, E. coli, C. albicans and S. aureus 
decreased with increasing concentrations of 
eugenol compounds (Table I and Figure. 3). 
 
Effect of Thymol and Eugenol against 
mid – phase polymicrobial biofilm (24h) 
The biofilm tested consisted of Gram-
positive bacteria i.e Staphylococus aureus and 
Gram-negative bacteria i.e Pseudomonas aeruginosa 
- Escherichia coli and yeast Candida albicans. 
Previous study found that bacteria 
synergistically can form biofilms with other 
bacterial species that difficult to penetrate by 
antibiotics compared to planktonic cells 
(Andersson et al., 2008). EPS matrices in 
biofilms may help cells survive longer by 
providing protection layers against antibiotics 
(Anderson et al., 2008; Leriche et al., 2003).  
Thymol 1% and eugenol 1%, each 
showed higher activity against Nystatin and 
Chloramphenicol of the same concentration. It 
was observed a concentration dependent 
antibiofilm activity towards a mid-phase 
polymicrobial biofilm (Table II and Figure 4). 
This value showed that the power of inhibiting 
activity of thymol and eugenol compound was 
strong and had potential as anti-biofilm 
medication’s candidate. 
 
Effect of Thymol and Eugenol against 
mono-speciesbiofilm maturation phase 
(48h) 
In the maturation phase, antimicrobial 
agents will have more difficulties to penetrate 
the biofilm and eugenol compounds have the 
potential to be antibiofilm. We observed 
decreasing in biofilm growth with increasing 
concentration of thymol and eugenol 
compounds, as described in (Table III, Figure 5 
and 6). 
Table I. Effect of thymoland eugenol against mono-species mid – phase biofilm (24h) 
 
Compound Bacterial Strains %  Inhibition MBIC50 v/v 
Thymol 1%  
P. aeruginosa 84.10±1.26* 0.13%  
E. coli 85.30±0.52* 0.29% 
C. albicans 84.40±1.85* 0.20%  
S. aureus  59.70±0.90* 0.51%  
 Eugenol 1%  
P. aeruginosa 86.86±1.15* 0.51%  
E. coli 82.87±0.62* 0.054%  
C. albicans 81.73±1.45* 0.06%  
S. aureus  57.56±0.51* 0.206%  
Chloramphenicol 1%  
P. aeruginosa 88.76±0.73*   
E. coli 77.95±0.83*   
S. aureus  59.02±1.10*   
Nystatin 1% C. albicans  70.67±0.36*   
 
Table II. Effect of thymol and eugenol against mid – phase polymicrobial biofilm (24h) 
 
Compound %  Inhibition MBIC50 v/v 
Thymol 1%  84.05±0.25* 0.10%  
Eugenol  1%  89.20±0.25* 0.31%  
Chloramphenicol 1% 69.82±1.96* 
 Nystatin 1%  55.70±0.72*  
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Thymol caused 50% damage in 
maturation phase of the mono-species             
P. aeruginosa, E. Coli, C. albicans and S. aureus. 
Antibiotic (chloramphenicol) and antifungal 
(nystatin 1%) that used as control showed a 
lower biofilm inhibition compared to thymol 
and eugenol compound. In biofilm inhibition 
of mono-species P.aeruginosa and C. albicans, 
thymol 1% showed higher activity against 
Chlorampenicol and nystatin of the same 
concentration (Table III). 
In this phase, the microbes that formed 
biofilm were already adhesive to the substrate, 
so those thymol and eugenol compounds were 
harder to kill the biofilm compared to the mid-
phase. In this phase, microbes were forming a 
strong biofilm defense system, and built a 
communication cell mechanism called quorum 
sensing. These made the antibiotics were hard to 
kill and damage the bacteria that formed biofilm.  
 
Effect of Thymol and Eugenol against 
polimicrobial biofilm phase (48h) 
Our results in figure 7 showed that 
thymol and eugenol with 0.5% concentration 
can damage the polymicrobial biofilm              
defense system for 50 %. On the concentration 
of 1% thymol and eugenol had inhibiting           
activites for 82.27±0.36% and 71.66±0.58%, 
while in antibiotic (chloramphenicol) and 
antifungal (nystatin 1%) showed a smaller 
inhibiting activity (Table IV). We reported           
that the eugenol activity on maturation        
phase of the polymicrobial biofilm was             
better compared to chloramphenicol. This 
showed that eugenol is potential to be 
developed and improved as the candidate for 
anti-biofilm. Eugenol at sub-inhibitory 
concentrations inhibited the produ-ction of 
virulence factors, including violacein, elastase, 
pyocyanin, and biofilm formation (Zhou et al., 
2013) 
MBIC50 values for polymicrobial biofilm 
maturation phase were 0.26% v/v (Thymol) 
and 0.50% v/v (Eugenol). This value showed 
that thymol and eugenol compounds had 
strong inhibiting activity, but eugenol MBIC50 
value on the middle-phase was better compared 
to the maturation phase, because in the 
maturition phase, the heterogeneous pattern 
was found in the biofilm, that interacted one 
and another  and  had more complex structure.  
Table III. Effect of thymol and eugenol against mono-species biofilm maturation phase (48h). 
 
Compound Bacterial Strains % Inhibition MBIC50 v/v 
Thymol 1%  
P. aeruginosa 84.82±0.30* 0.22% 
E. coli 80.34±0.78* 0.45% 
C. albicans 72.63±1.41* 0.43% 
S. aureus  55.21±1.70* 0.52% 
 Eugenol 1%  
P. aeruginosa 84.36±1.05* 0.26% 
E. coli 74.50±0.60* 0.51% 
C. albicans 74.91±0.55* 0.51% 
S. aureus  56.31±0.41* 0.62% 
Chloramphenicol 1%  
P. aeruginosa 79.66±0.20*   
E. coli 81.84±0.56*   
S. aureus  65.31±0.78*   
Nystatin 1% C. albicans  71.49±0.41*   
 
Table IV. Effect of thymol and eugenol against polimicrobial biofilm phase (48h). 
 
Compound %  Inhibition MBIC50 v/v 
Thymol 1%  82.27±0.36 * 0.26% 
Eugenol  1%  71.66±0.58 * 0.50%  
Chloramphenicol 1% 74.72±0.26 *  
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Figure 2. Effect of thymol against mono-
speciesmid – phasebiofilm. Blue= P. aeruginosa, 
Red= E.coli, Yellow= C.albicans, Green= S. aureus 
Figure 3. Effect of eugenol against mono-
speciesmid – phase biofilm. Blue= P. aeruginosa, 
Red= E.coli, Yellow =C.albicans, Green= S. aureus. 
 
  
Figure 4. Effect of thymol and eugenol against 
polymicrobial mid – phasebiofilm. Brown = 
Thymol, Green= Eugenol, Yellow=Nystatin, Red= 
Choloramfenicol. 
Figure 5. Effect of Thymol against mono-species 
maturation biofilm. Blue = P. aeruginosa, Red =E. 




Figure 6. Effect of eugenol against mono-species 
maturation biofilm. Blue= P. aeruginosa, Red=E. 
coli, Yellow=C. albicans, Green = S. aureus. 
Figure 7. Effect of thymol and eugenol against 
polymicrobial maturation biofilm. Brown = 
Thymol, Green= Eugenol, Yellow =Nystatin, Red = 
Choloramfenicol. 
 
Figure 8. Effect of thymol and eugenol against polymicrobial eradication biofilm. Brown = 
Thymol, Green= Eugenol, Yellow =Nystatin, Red = Choloramfenicol Green 
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          This is in accordance with Hamzah 
(2017) statement that interactions in biofilm 
bacteria can improve the ability of other 
bacterial species to survive and grow in aquatic 
environments that trigger rapid responses and 
result in complex biofilm formation. 
 
Effect of Thymol and Eugenol against 
polimicrobial biofilm phase eradication 
In polymicrobial biofilm P. aeruginosa 
rapidly triggered E. coli growth, making it 
possible to form a boarder biofilm area. The 
interaction with biofilm bacteria such as           
P. aeruginosa increased the ability of E. coli to 
survive and grow in an aquatic environment. In 
polymicrobial biofilm, they were well-organized 
in order to ful fill each others’ nutrition. We 
reported that thymol and eugenol degraded 
50% formation of C. albicans, P. aeruginosa,        
E. coli and S. aureus biofilm (Figure 8). 
It was harder to damage the microbes 
that formed biofilm compared to microbes that 
formed biofilm in a middle and inhibition 
phase. This caused by the longer growth time 
of biofilm, lead toformation of strong bacteria 
community so that antibiotics are difficult to 
penetrate. Matrices extracellular polymer 
subtances (EPS) in biofilms may help cells 
survive longer than if a set of conditions 
because EPS bound with water in an 
abundance amount so the microbes form a 
strong biofilm that had resistance toward 
drought, nutrients’ deficiency, anti-microbial 
substance and other conditions that brought 
disadvantages to the microbes’ growth. The 
EPS matrix on biofilms can help 
microorganism cells last longer than when              
they are in planktonic conditions, so it can           
help to microcortium various species of 
microorganisms in the degradation process 
(Donlan, 2002). 
In this study, we reported that thymol 
and eugenol compound had activity of biofilm 
damaging. The MBEC50 value of thymol and 
eugenol are 0.17 and 0.24 (*P<0.05) 
respectively. According to this study, it can be 
reported that the inhibition activities of thymol 
and eugenol compound in biofilm degradation 
phase were more potent compared to the 
control such as nystatin 56.66 % ± 0.96 %; 
while in chloramphenicol, the inhibition 
activitiesof thymol and eugenol compound in 
biofilm degradation phase were found almost 
similar 72.63±3.33%.  
Therefore effectiveness of thymol and 
eugenol against polymicrobial biofilm is an 
interesting thing to the discovery of new 
antibiofilm compounds as a therapeutic option 
for biofilm polymicrobial related infections. 
 
CONCLUSION 
Thymol and Eugenol potential as 
potential sources of novel antibiofilm 
candidates against polymicrobial biofilms C. 
albicans – P. aeruginosa - E. coli and S. aureus. 
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